Ship the analytics layer your biopharma customers are asking for
Your data asset is valuable but comparable data is available elsewhere. Your customers want feasibility, cohort extraction, and outcome analysis — not raw access. TrialMind embeds by API or MCP, white-label or co-branded, deployed in the customer's environment, in weeks.
The product layer, without the product organisation
Ships as your product
Your biopharma customers increasingly want feasibility, cohort extraction, and outcome analysis rather than raw data access. TrialMind embeds by API or MCP, white-label or co-branded, so the capability arrives under your brand rather than as an obvious third-party dependency.
Weeks, not a product organisation
Building this yourself means standing up a clinical analytics product organisation you do not have and do not want. The agents and tool infrastructure already exist, so embedding is measured in weeks and does not start with hiring a clinical domain team.
Deploys where the data already is
The first objection your biopharma customers raise is where their data goes. TrialMind deploys into the customer's own environment with raw data never leaving it — answered architecturally, so you are not negotiating it deal by deal.
Answers the objection your customers raise first
Data partnerships stall on where the data goes and whether the analysis can be defended. Both are properties of the architecture here.
Raw data never moves
Deployment into the customer's environment is the default. This is the objection that stops data partnerships, and it is answered in the architecture rather than in a contract clause.
Audit trails end to end
Your customers take these outputs into regulatory submissions, so every analysis carries traceable, reproducible provenance.
Built to your roadmap
We are small enough to build against your product plan rather than asking you to wait for ours.
Frequently Asked Questions
How does the integration actually work?
Two paths. A REST API for conventional product integration, and an MCP server if you want the agents callable as tools from your own assistant or workflow layer. Most partners start with the API and add MCP once they know which workflows their customers use most.
Can we white-label it?
Yes. White-label or co-branded, whichever fits your positioning. The point is that it ships as your product rather than as a visible third-party dependency inside it.
Where does our customers' data go?
Nowhere. TrialMind deploys into the customer's own environment and raw records never leave it. This is usually the first question your biopharma customers ask, and it is answered by the deployment model rather than by a data processing agreement.
How long does an embed take?
Weeks rather than years, because the agents and tool infrastructure already exist. What varies is the depth of integration with your platform, not the time to build clinical analytics capability from scratch.
Who owns the customer relationship?
You do. We are the layer inside your product, and we attribute any biopharma customer onboarded through it. We are explicit about this at the start so that neither side is guessing later.
What if we later build this ourselves?
That is a reasonable thing for you to consider, and we would rather structure the agreement knowing it than pretend otherwise. What we ask for is a clear commercial framework across the workstreams rather than one negotiated in isolation.